359779-74-1 Usage
Uses
Used in Pharmaceutical Industry:
Tert-butyl 3-oxo-6-azabicyclo[3.2.1]octane-6-carboxylate is used as a building block in the synthesis of pharmaceuticals for its ability to contribute to the creation of diverse molecules with potential therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical industry, tert-butyl 3-oxo-6-azabicyclo[3.2.1]octane-6-carboxylate is utilized as a key intermediate in the development of various agrochemicals, taking advantage of its reactivity and structural properties to produce compounds with pesticidal or herbicidal activities.
Used in Organic Synthesis:
Tert-butyl 3-oxo-6-azabicyclo[3.2.1]octane-6-carboxylate serves as a versatile intermediate in organic synthesis, allowing chemists to construct a wide range of organic compounds with potential applications in various fields, including materials science, fragrances, and dyes.
Check Digit Verification of cas no
The CAS Registry Mumber 359779-74-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,9,7,7 and 9 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 359779-74:
(8*3)+(7*5)+(6*9)+(5*7)+(4*7)+(3*9)+(2*7)+(1*4)=221
221 % 10 = 1
So 359779-74-1 is a valid CAS Registry Number.
359779-74-1Relevant academic research and scientific papers
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR RELIEVING PAIN AND TREATING CENTRAL NERVOUS SYSTEM DISORDERS
-
Page/Page column 68-69, (2008/06/13)
Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia), are treated by administering a compound of Formulas (1 or 2), as described herein. The compounds of Formulas (1 and 2) are also useful for treating pain, and treating drug addiction, nicotine addiction, and/or obesity. The compounds can exist as individual stereoisomers, racemic mixtures, diastereomers and the like.
